Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 65, doi. 10.1002/ddr.21063
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2013 AND VI 74 AND IP 2
Results: 8
1
2
Proteolytic Enzymes as Biomarkers of Focal Segmental Glomerulosclerosis.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 81, doi. 10.1002/ddr.21062
- By:
- Publication type:
- Article
3
Alzheimer's Disease Biomarkers: More Than Molecular Diagnostics.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 92, doi. 10.1002/ddr.21073
- By:
- Publication type:
- Article
4
Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 138, doi. 10.1002/ddr.21072
- By:
- Publication type:
- Article
5
Advancing Renewable Normal Human Cell Assays for Drug Discovery.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 127, doi. 10.1002/ddr.21069
- By:
- Publication type:
- Article
6
Biomarkers-An Essential Tie That Binds the Future of Drugs and Diagnostics.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 63, doi. 10.1002/ddr.21071
- By:
- Publication type:
- Article
7
Integrating Companion Diagnostic Assays into Drug Development: Addressing the Challenges from the Diagnostic Perspective.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 148, doi. 10.1002/ddr.21068
- By:
- Publication type:
- Article
8
Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium.
- Published in:
- Drug Development Research, 2013, v. 74, n. 2, p. 112, doi. 10.1002/ddr.21070
- By:
- Publication type:
- Article